Femasys Inc
FEMY0.861USD
+0.064+7.97%
收盤 12/19, 16:00（美東）報價延遲15分鐘
40.73M總市值
虧損本益比TTM
關於 Femasys Inc 公司
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Femasys Inc簡介
公司代碼FEMY
公司名稱Femasys Inc
上市日期Jun 18, 2021
CEOLee-Sepsick (Kathy)
員工數量69
證券類型Ordinary Share
年結日Jun 18
公司地址3950 Johns Creek Court
城市SUWANEE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編30024
電話17705003910
網址https://www.femasys.com/
公司代碼FEMY
上市日期Jun 18, 2021
CEOLee-Sepsick (Kathy)
Femasys Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
432.85K
+12.63%
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
5.67K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
80.00
--
Mr. Dov Elefant
Mr. Dov Elefant
Chief Financial Officer
Chief Financial Officer
--
--
Dr. James Liu, M.D.
Dr. James Liu, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Independent Director
Independent Director
--
--
Mr. Daniel Currie
Mr. Daniel Currie
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Edward Uzialko, Jr.
Mr. Edward Uzialko, Jr.
Independent Director
Independent Director
--
--
Ms. Christine Thomas
Ms. Christine Thomas
Chief Regulatory and Clinical Officer
Chief Regulatory and Clinical Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Kathy Lee-Sepsick
Ms. Kathy Lee-Sepsick
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
432.85K
+12.63%
Mr. Alistair Milnes
Mr. Alistair Milnes
Independent Director
Independent Director
5.67K
--
Ms. Kelley Nicholas
Ms. Kelley Nicholas
Chief Commercial Officer
Chief Commercial Officer
80.00
--
Mr. Dov Elefant
Mr. Dov Elefant
Chief Financial Officer
Chief Financial Officer
--
--
Dr. James Liu, M.D.
Dr. James Liu, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Charles E. Larsen
Mr. Charles E. Larsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
收入明細
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
United States
409.27K
0.00%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 12月4日 週四
更新時間: 12月4日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Chernett (Jorey)
5.19%
Dauntless Investment Group, LLC
2.96%
Uzialko (Edward R Jr.)
2.08%
The Vanguard Group, Inc.
1.63%
Alumni Capital Management LLC
1.59%
其他
86.55%
持股股東
持股股東
佔比
Chernett (Jorey)
5.19%
Dauntless Investment Group, LLC
2.96%
Uzialko (Edward R Jr.)
2.08%
The Vanguard Group, Inc.
1.63%
Alumni Capital Management LLC
1.59%
其他
86.55%
股東類型
持股股東
佔比
Individual Investor
8.41%
Investment Advisor
5.54%
Investment Advisor/Hedge Fund
2.29%
Venture Capital
0.08%
Research Firm
0.04%
Bank and Trust
0.03%
Hedge Fund
0.03%
其他
83.57%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
53
6.06M
9.41%
--
2025Q3
60
6.06M
10.92%
+931.90K
2025Q2
65
5.13M
15.23%
+1.22M
2025Q1
62
3.90M
17.97%
-962.46K
2024Q4
57
2.39M
11.54%
+713.58K
2024Q3
55
1.67M
11.99%
+32.62K
2024Q2
57
1.64M
11.51%
+117.87K
2024Q1
57
1.52M
11.83%
-1.09M
2023Q4
56
1.43M
10.18%
-232.64K
2023Q3
51
1.66M
10.47%
+405.22K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Chernett (Jorey)
3.03M
7.05%
+1.41M
+86.81%
Jun 30, 2025
Dauntless Investment Group, LLC
2.32M
5.4%
+745.63K
+47.34%
Jun 30, 2025
Uzialko (Edward R Jr.)
1.22M
2.83%
--
--
Apr 08, 2025
The Vanguard Group, Inc.
951.87K
2.21%
+126.20K
+15.28%
Jun 30, 2025
Alumni Capital Management LLC
931.90K
2.17%
+931.90K
--
Sep 04, 2025
Lee-Sepsick (Kathy)
432.85K
1.01%
+48.53K
+12.63%
Aug 27, 2025
Geode Capital Management, L.L.C.
251.39K
0.58%
+5.89K
+2.40%
Jun 30, 2025
Clear Creek Financial Management, LLC
281.82K
0.66%
+11.45K
+4.23%
Jun 30, 2025
Currie (Daniel Scott)
109.24K
0.25%
+19.61K
+21.88%
Jun 02, 2025
BlackRock Institutional Trust Company, N.A.
92.41K
0.21%
+56.73K
+159.00%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Femasys Inc的前五大股東是誰？
Femasys Inc的前五大股東如下：
Chernett (Jorey)持有股份：3.03M佔總股份比例：7.05%。
Dauntless Investment Group, LLC持有股份：2.32M佔總股份比例：5.40%。
Uzialko (Edward R Jr.)持有股份：1.22M佔總股份比例：2.83%。
The Vanguard Group, Inc.持有股份：951.87K佔總股份比例：2.21%。
Alumni Capital Management LLC持有股份：931.90K佔總股份比例：2.17%。
Chernett (Jorey)持有股份：3.03M佔總股份比例：7.05%。
Dauntless Investment Group, LLC持有股份：2.32M佔總股份比例：5.40%。
Uzialko (Edward R Jr.)持有股份：1.22M佔總股份比例：2.83%。
The Vanguard Group, Inc.持有股份：951.87K佔總股份比例：2.21%。
Alumni Capital Management LLC持有股份：931.90K佔總股份比例：2.17%。
Femasys Inc的前三大股東類型是什麼？
Femasys Inc 的前三大股東類型分別是：
Chernett (Jorey)
Dauntless Investment Group, LLC
Uzialko (Edward R Jr.)
Chernett (Jorey)
Dauntless Investment Group, LLC
Uzialko (Edward R Jr.)
有多少機構持有Femasys Inc(FEMY)的股份？
截至2025Q4，共有53家機構持有Femasys Inc的股份，合計持有的股份價值約為6.06M，占公司總股份的9.41% 。與2025Q3相比，機構持股有所增加，增幅為-1.52%。
哪個業務部門對Femasys Inc的收入貢獻最大？
在FY2025Q2，--業務部門對Femasys Inc的收入貢獻最大，創收--，占總收入的--% 。
